| Host: |
HEK293 cells |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Formulation: |
Lyophilised from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Determination Method: |
< 0.01 EU/Mu g |
| Gene Symbol: |
Il6ra |
| Gene ID: |
16194 |
| Uniprot ID: |
IL6RA_MOUSE |
| Immunogen Region: |
Leu 20-Glu 357 |
| Immunogen: |
Recombinant Mouse IL-6RA/CD126 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Leu 20-Glu 357) of Mouse Il6ra (Accession #NP_034689.2) fused with His tag at the C-terminus. |
| Immunogen Sequence: |
LVLGSCRALEVANGTVTSLP GATVTLICPGKEAAGNVTIH WVYSGSQNREWTTTGNTLVL RDVQLSDTGDYLCSLNDHLV GTVPLLVDVPPEEPKLSCFR KNPLVNAICEWRPSSTPSPT TKAVLFAKKINTTNGKSDFQ VPCQYSQQLKSFSCQVEILE GDKVYHIVSLCVANSVGSKS SHNEAFHSLKMVQPDPPANL VVSAIPGRPRWLKVSWQHPE TWDPSYYLLQFQLRYRPVW |
| Post Translational Modifications | A short soluble form is also released from the membrane by proteolysis. The sIL6R is formed by limited proteolysis of membrane-bound receptors, a process referred to as ectodomain shedding. mIL6R is cleaved by the proteases ADAM10 and ADAM17. Glycosylated. Glycosylation is dispensable for transport, signaling, and cell-surface turnover. Glycosylation at Asn-55 is a protease-regulatory exosite. Glycosylation is required for ADAM17-mediated proteolysis. |
| Function | Part of the receptor for interleukin 6. Binds to IL6 with low affinity, but does not transduce a signal. Signal activation necessitate an association with IL6ST. Activation leads to the regulation of the immune response, acute-phase reactions and hematopoiesis. The interaction with membrane-bound IL6R and IL6ST stimulates 'classic signaling', the restricted expression of the IL6R limits classic IL6 signaling to only a few tissues such as the liver and some cells of the immune system. Whereas the binding of IL6 and soluble IL6R to IL6ST stimulates 'trans-signaling'. Alternatively, 'cluster signaling' occurs when membrane-bound IL6:IL6R complexes on transmitter cells activate IL6ST receptors on neighboring receiver cells. Interleukin-6 receptor subunit alpha: Signaling via the membrane-bound IL6R is mostly regenerative and anti-inflammatory (Probable). Drives naive CD4(+) T cells to the Th17 lineage, through 'cluster signaling' by dendritic cells. Soluble interleukin-6 receptor subunit alpha: Soluble form of IL6 receptor (sIL6R) that acts as an agonist of IL6 activity. The IL6:sIL6R complex (hyper-IL6) binds to IL6ST/gp130 on cell surfaces and induces signaling also on cells that do not express membrane-bound IL6R in a process called IL6 'trans-signaling'. sIL6R is causative for the pro-inflammatory properties of IL6 and an important player in the development of chronic inflammatory diseases. In complex with IL6, is required for induction of VEGF production. Plays a protective role during liver injury, being required for maintenance of tissue regeneration. 'Trans-signaling' in central nervous system regulates energy and glucose homeostasis. |
| Protein Name | Interleukin-6 Receptor Subunit AlphaIl-6 Receptor Subunit AlphaIl-6r Subunit AlphaIl-6r-AlphaIl-6raIl-6r 1Cd Antigen Cd126 Cleaved Into - Soluble Interleukin-6 Receptor Subunit AlphaSil6r |
| Database Links | Reactome: R-MMU-1059683Reactome: -MMU-110056Reactome: -MMU-112411 |
| Cellular Localisation | Interleukin-6 Receptor Subunit Alpha: Cell MembraneSingle-Pass Type I Membrane ProteinSoluble Interleukin-6 Receptor Subunit Alpha: Secreted |
| Alternative Protein Names | Interleukin-6 Receptor Subunit Alpha proteinIl-6 Receptor Subunit Alpha proteinIl-6r Subunit Alpha proteinIl-6r-Alpha proteinIl-6ra proteinIl-6r 1 proteinCd Antigen Cd126 Cleaved Into - Soluble Interleukin-6 Receptor Subunit Alpha proteinSil6r proteinIl6ra proteinIl6r protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
